Click the three-dot button next to " Basic Portfolio, " then " Duplicate Portfolio " (not shown). This way, you can ...

Local History columnist Ross Eric Gibson tells the story of how harpsichordist Roy Stegman joined Concertino Strings.

From a cushy adjustable pillow to cult-favorite earbuds, these are the products our readers loved most across our best picks ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and ...

Detailed price information for Pantheon Res Plc Ord (PTHRF) from The Globe and Mail including charting and trades.

Spain: Researchers have found in a new study that sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a neutral effect on ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...

Williams, A. and Louis, L. (2026) Cumulative Link Modeling of Ordinal Outcomes in the National Health Interview Survey Data: Application to Depressive Symptom Severity. Journal of Data Analysis and ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

Just one week left. We’re over 70% of the way to our year-end goal — and now is the moment. If you’ve been meaning to support ...